About the Company
Jeffery Alan Smisek (born August 17, 1954) is an American businessman, who is the president of GOOSE Capital and on the board of directors of Finch Therapeutics. Smisek previously worked in the airline industry as the chairman, president, and chief executive officer (CEO) of Continental Airlines and, later, of United Airlines.
Exchange
OTC
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Finch Therapeutics Group, Inc.
As Finch Therapeutics Group, Inc.'s market cap (NASDAQ:FNCH) drops to ...
Insiders who acquired US$650k worth of Finch Therapeutics Group, Inc.'s (NASDAQ:FNCH) stock at an average price of US$10.18 in the past 12 months may be dismayed by the recent 14% price decline ...
FNCH | Finch Therapeutics Group Inc. Stock Price & News - WSJ
View the latest Finch Therapeutics Group Inc. (FNCH) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Finch Therapeutics Reports First Quarter 2023 Financial Results and ...
SOMERVILLE, Mass., May 10, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (FNCH), a microbiome technology company with a portfolio of intellectual property and microbiome assets, today ...
Finch Therapeutics Group Inc FNCH - Morningstar
Find out if Finch Therapeutics Group Inc (FNCH:PINX) stock is overpriced or undervalued based on Morningstar's evaluation. Assess the current comparison of market prices to the Fair Value of the ...
Finch Therapeutics Group Inc. Stock Grades | FNCH | Barron's
Finch Therapeutics Group Inc. stock grades by Barron's. View FNCH fundamental and sentiment analysis powered by MarketGrader.
Finch Therapeutics Presents PRISM-EXT Biomarker Data at ACG 2022 and ...
(858) 525-2047 stephen@gilmartinir.com Media Contact: Jenna Urban Berry & Company Public Relations (212) 253-8881 jurban@berrypr.com Source: Finch Therapeutics Group, Inc. 2022 GlobeNewswire, Inc.
Finch Therapeutics Announces Executive Leadership Transitions
--Finch Therapeutics Group, Inc., a microbiome technology company with a portfolio of intellectual property and microbiome assets, today announced the appointment of Matthew P. Blischak as Chief ...
Finch Therapeutics Group Inc FNCH - Morningstar
Learn about the executive team and board of directors at Finch Therapeutics Group Inc (FNCH:PINX) and review their bios and compensation over the latest fiscal years.
Similar Companies
Loading the latest forecasts...